Search

Search Results

1. Preclinical evaluation of [¹⁸F]SYN1 and [¹⁸F]SYN2, novel radiotracers for PET myocardial perfusion imaging

   Background

   Positron emission tomography (PET) is now an established diagnostic method for myocardial perfusion imaging (MPI) in coronary artery...

   Seweryn Krajewski, Lukasz Steczek, ... Cezary Kozanecki in EJNMMI Research

   Article Open access 08 July 2024
   

2. cGMP compliant one-step, one-pot automated [¹⁸F]FBnTP production for clinical imaging of mitochondrial activity

   Background

   4-[ ¹⁸ F]fluorobenzyl-triphenylphosphonium ([ ¹⁸ F]FBnTP) is a lipophilic cation PET tracer. The cellular uptake of [ ¹⁸ F]FBnTP is correlated...

   Mai Lin, Cong-Dat Pham, ... H. Charles Manning in EJNMMI Radiopharmacy and Chemistry

   Article Open access 27 June 2024
   

3. Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan

   Marc Østergaard Nielsen, Hanne Schledermann, Lars Thorbjørn Jensen in Journal of Nuclear Cardiology

   Article 16 February 2023
   

4. ⁸⁹Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations

   Background

   The non-invasive imaging of leukocyte trafficking to assess inflammatory areas and monitor immunotherapy is currently generating great...

   Maryke Kahts, Hua Guo, ... Omer Aras in EJNMMI Radiopharmacy and Chemistry

   Article Open access 06 November 2023
   

5. On site production of [¹⁸F]PSMA-1007 using different [¹⁸F]fluoride activities: practical, technical and economical impact

   Background

   Prostate-specific membrane antigen is overexpressed in prostate cancer and it is considered a good target for positron emission...

   Costantina Maisto, Anna Morisco, ... Secondo Lastoria in EJNMMI Radiopharmacy and Chemistry

   Article Open access 13 October 2021
   

6. Time-related study on external exposure dose of 2-deoxy-2-[F-18]fluoro-d-glucose PET for workers’ safety

   Time-course study of individual dose equivalents of 2-deoxy-2-[F-18]fluoro- d -glucose positron emission tomography ( ¹⁸ F-FDG PET) was conducted in...

   Yasuyuki Takahashi, Shota Hosokawa, ... Noboru Oriuchi in Radiological Physics and Technology

   Article 12 December 2019
   

7. Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET

   Bruno B. Lima, Dominik C. Benz in Journal of Nuclear Cardiology

   Article 20 September 2023

8. Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance

   In light of the United States Food and Drug Administration (FDA) requirement of 21 CFR 212 current Good Manufacturing Practice (cGMP) for...

   Shaojun Zhu, Sherly Mosessian, ... Michael Phelps in Molecular Imaging and Biology

   Article Open access 25 June 2019
   

9. Engineering a modular ⁴⁴Ti/⁴⁴Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry

   Background

   ⁴⁴ Sc/ ⁴⁷ Sc is an attractive theranostic pair for targeted in vivo positron emission tomographic (PET) imaging and beta-particle treatment...

   Nadia Benabdallah, Hanwen Zhang, ... Daniel L. J. Thorek in EJNMMI Research

   Article Open access 28 February 2023
   

10. Imaging of cardiac sympathetic dysfunction with 18F-FDOPA PET/CT in patients with heart failure: a pilot study

    Background

    Routine use of cardiac sympathetic imaging in HF has been limited by the lower availability/sensitivity of radiotracers. This study was...

    Thayumanavan Thanigainathan, Anshul Sharma, ... Chandra Shekhar Bal in Journal of Nuclear Cardiology

    Article 06 December 2022
    

11. A comparison study of dynamic [¹⁸F]Alfatide II imaging and [¹¹C]MET in orthotopic rat models of glioblastoma

    Purpose

    To investigate and compare the dynamic positron emission tomography (PET) imaging with [ ¹⁸ F]Alfatide II Imaging and [ ¹¹ C]Methionine ([ ¹¹ C]MET)...

    Yue Pan, Haodan Dang, ... Baixuan Xu in Journal of Cancer Research and Clinical Oncology

    Article Open access 22 April 2024
    

12. Current status and perspectives of nuclear cardiology

    Nuclear cardiology has long been used to identify myocardial ischemia for appropriate treatment strategies for stable coronary artery disease (CAD)....

    Nagara Tamaki, Osamu Manabe in Annals of Nuclear Medicine

    Article 27 October 2023
    

13. Go with the Flow!

    Dennis A. Calnon in Journal of Nuclear Cardiology

    Article 23 June 2022
    

14. Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear Techniques

    Purpose of Review

    Statins are routinely applied in patients with coronary artery disease, as they allow significantly to reduce blood cholesterol...

    Takahiro Higuchi, Sebastian E. Serfling, ... Rudolf A. Werner in Current Cardiology Reports

    Article Open access 13 October 2022
    

15. Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET

    Background

    The brain is a challenging target for antibody-based positron emission tomography (immunoPET) imaging due to the restricted access of...

    Eva Schlein, Johanna Rokka, ... Jonas Eriksson in EJNMMI Radiopharmacy and Chemistry

    Article Open access 06 March 2024
    

16. Creation, evolution, and future challenges of ion beam therapy from a medical physicist’s viewpoint (Part 3): Chapter 3. Clinical research, Chapter 4. Future challenges, Chapter 5. Discussion, and Conclusion

    Clinical studies of ion beam therapy have been performed at the Lawrence Berkeley Laboratory (LBL), National Institute of Radiological Sciences...

    Masahiro Endo in Radiological Physics and Technology

    Article 26 October 2023
    

17. Letter to Editor for “European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees.”

    Humayun Bashir, Muhammad Numair Younis, Hamid Naseer in European Journal of Nuclear Medicine and Molecular Imaging

    Article 13 December 2022

18. Experience of 6-l-[¹⁸F]FDOPA Production Using Commercial Disposable Cassettes and an Automated Module

    Purpose

    The clinical demand of 6 - l -[ ¹⁸ F] FDOPA is gaining rapidly for imaging neurodegenerative diseases by using positron emission tomography....

    Raviteja Nanabala, Maroor Raghavan Ambikalmajan Pillai, Buvaneswari Gopal in Nuclear Medicine and Molecular Imaging

    Article 06 April 2022
    

19. High molar activity [¹⁸F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET

    Background

    Sodium iodide symporter (NIS) imaging by positron emission tomography (PET) is gaining traction in nuclear medicine, with an increasing...

    Dmitry Soloviev, Piotr Dzien, ... David Lewis in EJNMMI Radiopharmacy and Chemistry

    Article Open access 13 December 2022
    

20. The utility of PET for detecting corticotropinomas in Cushing disease: a sco** review

    While magnetic resonance imaging (MRI) is the current standard imaging method for diagnosing and localizing corticotropinomas in Cushing disease, it...

    Megan M. J. Bauman, Jeffrey P. Graves, ... Jamie J. Van Gompel in Neurosurgical Review

    Article 01 July 2023